Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Rang in aandelen
#3509
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Aandeelprijs
$3.86
Marktkapitalisatie
$4.88B
Verandering (1 dag)
4.10%
Verandering (1 jaar)
-50.30%
Land
CN
Handel Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Categorie
Healthcare
Omzet van Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Omzet in Jun 2026 TTM: $293.29M
Volgens de laatste financiële rapporten van Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. bedraagt de huidige omzet van het bedrijf (TTM) $293.29M. In 2023 behaalde het bedrijf een omzet van $778.51M een daling ten opzichte van de omzet in het jaar 2022, die $1.62B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. van 2013 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $293.29M | -4.66% |
| 2024 | $307.63M | -60.49% |
| 2023 | $778.51M | -51.99% |
| 2022 | $1.62B | 79.23% |
| 2021 | $904.72M | 151.05% |
| 2020 | $360.38M | 111.99% |
| 2019 | $170.00M | 19.00% |
| 2018 | $142.86M | -2.11% |
| 2017 | $145.94M | 20.04% |
| 2016 | $121.57M | 15.98% |
| 2015 | $104.83M | 8.90% |
| 2014 | $96.26M | 17.00% |
| 2013 | $82.27M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| $12.62B | 4,204.41% |
US
|
|
| $2.23B | 659.66% |
US
|
|
| $15.74B | 5,268.23% |
AU
|
|
| $6.02B | 1,953.03% |
NL
|
|
| - | - |
CH
|
